NXY-059: brain or vessel protection.
Fisher
Marc
M
Acute Stroke Programme, Nuffield Department of Medicine, Level 7, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom.
Lees
Kennedy
K
Papadakis
Michalis
M
Buchan
Alastair M
AM
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004359:Drug Therapy, Combination; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009589:Nitrogen Oxides / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy* / Q000503:physiopathology; D015912:Thrombolytic Therapy
D000975:Antioxidants; D001557:Benzenesulfonates; D018696:Neuroprotective Agents; D009589:Nitrogen Oxides; C120851:disufenton sodium